23andMe
DNA genetic testing for health, ancestry and more.
23andMe is a direct-to-consumer genetic testing service that analyzes a saliva sample to provide personalized insights into ancestry, health risks, carrier status, traits, and pharmacogenetics. The company offers tiered subscription plans ranging from basic ancestry reports to a comprehensive longevity-focused health platform that combines DNA analysis with blood testing. It is the first direct-to-consumer DNA service to receive multiple FDA-cleared health reports.
Users purchase a kit, provide a saliva sample, mail it to a lab, and receive personalized genetic reports in a secure online account within a few weeks.
General consumers interested in learning about their ancestry, genetic health risks, and personal traits
Background.
- Status
- launched
- Business model
- subscription
- Company
- 23andMe Holding Co.
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.